Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 99

1.

Up-regulation of serotonin receptor 2B mRNA and protein in the peri-infarcted area of aged rats and stroke patients.

Buga AM, Ciobanu O, Bădescu GM, Bogdan C, Weston R, Slevin M, Di Napoli M, Popa-Wagner A.

Oncotarget. 2016 Apr 5;7(14):17415-30. doi: 10.18632/oncotarget.8277.

2.

Acute fluoxetine exposure alters crab anxiety-like behaviour, but not aggressiveness.

Hamilton TJ, Kwan GT, Gallup J, Tresguerres M.

Sci Rep. 2016 Jan 25;6:19850. doi: 10.1038/srep19850.

3.

Trazodone regulates neurotrophic/growth factors, mitogen-activated protein kinases and lactate release in human primary astrocytes.

Daniele S, Zappelli E, Martini C.

J Neuroinflammation. 2015 Dec 1;12:225. doi: 10.1186/s12974-015-0446-x.

4.

Selective serotonin reuptake inhibitors to improve outcome in acute ischemic stroke: possible mechanisms and clinical evidence.

Siepmann T, Penzlin AI, Kepplinger J, Illigens BM, Weidner K, Reichmann H, Barlinn K.

Brain Behav. 2015 Sep 23;5(10):e00373. doi: 10.1002/brb3.373. Review.

5.

Serotonin 6 receptor controls Alzheimer's disease and depression.

Yun HM, Park KR, Kim EC, Kim S, Hong JT.

Oncotarget. 2015 Sep 29;6(29):26716-28. doi: 10.18632/oncotarget.5777.

6.

Regulation of astrocyte pathology by fluoxetine prevents the deterioration of Alzheimer phenotypes in an APP/PS1 mouse model.

Qiao J, Wang J, Wang H, Zhang Y, Zhu S, Adilijiang A, Guo H, Zhang R, Guo W, Luo G, Qiu Y, Xu H, Kong J, Huang Q, Li XM.

Glia. 2016 Feb;64(2):240-54. doi: 10.1002/glia.22926.

PMID:
26446044
7.

New Findings on the Neurotransmitter Modulation of Defense in the Dorsal Periaqueductal Gray.

Graeff FG, Sant'Ana AB, Vilela-Costa HH, Zangrossi H Jr.

CNS Neurol Disord Drug Targets. 2015;14(8):988-95. Review.

PMID:
26350338
8.

Serotonergic dysfunction in the A53T alpha-synuclein mouse model of Parkinson's disease.

Deusser J, Schmidt S, Ettle B, Plötz S, Huber S, Müller CP, Masliah E, Winkler J, Kohl Z.

J Neurochem. 2015 Nov;135(3):589-97. doi: 10.1111/jnc.13253.

9.

The Effects of Pretreatment versus De Novo Treatment with Selective Serotonin Reuptake Inhibitors on Short-term Outcome after Acute Ischemic Stroke.

Siepmann T, Kepplinger J, Zerna C, Schatz U, Penzlin AI, Pallesen LP, Illigens BM, Weidner K, Reichmann H, Puetz V, Bodechtel U, Barlinn K.

J Stroke Cerebrovasc Dis. 2015 Aug;24(8):1886-92. doi: 10.1016/j.jstrokecerebrovasdis.2015.04.033.

PMID:
26099557
10.

Morphine-Induced Constipation Develops With Increased Aquaporin-3 Expression in the Colon via Increased Serotonin Secretion.

Kon R, Ikarashi N, Hayakawa A, Haga Y, Fueki A, Kusunoki Y, Tajima M, Ochiai W, Machida Y, Sugiyama K.

Toxicol Sci. 2015 Jun;145(2):337-47. doi: 10.1093/toxsci/kfv055.

PMID:
25766885
11.

Fluoxetine prevents the development of depressive-like behavior in a mouse model of cancer related fatigue.

Norden DM, Devine R, Bicer S, Jing R, Reiser PJ, Wold LE, Godbout JP, McCarthy DO.

Physiol Behav. 2015 Mar 1;140:230-5. doi: 10.1016/j.physbeh.2014.12.045.

12.

Biomarkers for assessing population and individual health and disease related to stress and adaptation.

McEwen BS.

Metabolism. 2015 Mar;64(3 Suppl 1):S2-S10. doi: 10.1016/j.metabol.2014.10.029. Review.

PMID:
25496803
13.

Expression of the 5-HT1A serotonin receptor in the hippocampus is required for social stress resilience and the antidepressant-like effects induced by the nicotinic partial agonist cytisine.

Mineur YS, Einstein EB, Bentham MP, Wigestrand MB, Blakeman S, Newbold SA, Picciotto MR.

Neuropsychopharmacology. 2015 Mar;40(4):938-46. doi: 10.1038/npp.2014.269.

14.

Life-long consequences of juvenile exposure to psychotropic drugs on brain and behavior.

Steiner H, Warren BL, Van Waes V, Bolaños-Guzmán CA.

Prog Brain Res. 2014;211:13-30. doi: 10.1016/B978-0-444-63425-2.00002-7. Review.

15.

Fluoxetine: juvenile pharmacokinetics in a nonhuman primate model.

Golub MS, Hogrefe CE.

Psychopharmacology (Berl). 2014 Oct;231(20):4041-7. doi: 10.1007/s00213-014-3537-y.

16.

Effects of Sini San used alone and in combination with fluoxetine on central and peripheral 5-HT levels in a rat model of depression.

Li Y, Sun Y, Ma X, Xue X, Zhang W, Wu Z, Ouyang Y, Chen J, Wang W, Guo S, Wang W.

J Tradit Chin Med. 2013 Oct;33(5):674-81.

17.

APP-dependent alteration of GSK3β activity impairs neurogenesis in the Ts65Dn mouse model of Down syndrome.

Trazzi S, Fuchs C, De Franceschi M, Mitrugno VM, Bartesaghi R, Ciani E.

Neurobiol Dis. 2014 Jul;67:24-36. doi: 10.1016/j.nbd.2014.03.003.

PMID:
24636797
18.

5-HT1A/1B receptors as targets for optimizing pigmentary responses in C57BL/6 mouse skin to stress.

Wu HL, Pang SL, Liu QZ, Wang Q, Cai MX, Shang J.

PLoS One. 2014 Feb 21;9(2):e89663. doi: 10.1371/journal.pone.0089663.

19.

Fluoxetine administered to juvenile monkeys: effects on the serotonin transporter and behavior.

Shrestha SS, Nelson EE, Liow JS, Gladding R, Lyoo CH, Noble PL, Morse C, Henter ID, Kruger J, Zhang B, Suomi SJ, Svenningsson P, Pike VW, Winslow JT, Leibenluft E, Pine DS, Innis RB.

Am J Psychiatry. 2014 Mar;171(3):323-31. doi: 10.1176/appi.ajp.2013.13020183.

20.

Use of fluoxetine in anorexia nervosa before and after weight restoration.

Sebaaly JC, Cox S, Hughes CM, Kennedy ML, Garris SS.

Ann Pharmacother. 2013 Sep;47(9):1201-5. doi: 10.1177/1060028013503127. Review.

PMID:
24259736
Items per page

Supplemental Content

Loading ...
Support Center